3-iodobenzylguanidine has been researched along with Carcinoma, Medullary in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (52.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| Aliberti, G; Bombardieri, E; Castellani, MR; Chiesa, C; Maccauro, M; Orunesu, E; Seregni, E | 1 |
| McEwan, AJ; Postema, EJ | 1 |
| Drozd, T; Green, P; Hamdan, A; Hirsch, D; Molad, Y; Neumann, A | 1 |
| An, R; Biersack, HJ; Ezziddin, S; Gao, Z; Logvinski, T | 1 |
| Aoi, S; Fumino, S; Iwai, N; Shimotake, T; Tsuda, T | 1 |
| Baum, RP; Calcagni, ML; Rufini, V | 1 |
| An, R; Biersack, HJ; Gao, ZR; Zhang, YX | 1 |
| Al-Nahhas, A; Castaldi, P; Gross, MD; Perotti, G; Rubello, D; Rufini, V; Treglia, G | 1 |
| Bito, S; Dan, Y; Hino, M; Ikekubo, K; Ito, H; Masui, Y; Ohta, K; Ootsuka, H; Saiki, Y; Yamaguchi, H | 1 |
| Albertson, DA; Cooper, MR; Cowan, RJ; Thomas, CC | 1 |
| D'Ajello, M; Marzano, LA; Porcelli, A; Zarrilli, L; Zarrilli, S | 1 |
| Advani, SH; Kurkure, PA; Murugesan, S; Noronha, OP; Samuel, AM; Sonawane, GA | 1 |
| Endo, K; Hirano, T; Inoue, T; Ishida, T; Tomiyoshi, K; Zhang, YJ | 1 |
| Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
| Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
| Han, R; Mitrovic, S; Zagar, I | 1 |
| Casolo, A; Corsello, SM; Martino, G; Maussier, ML; Pantusa, M; Rufini, V; Saletnich, I; Salvatori, M; Troncone, L; Valenza, V | 1 |
| Acampa, W; Bernardy, JD; Klain, M; Lastoria, S; Maurea, S; Muto, P; Salvatore, M; Varrella, P; Vergara, E | 1 |
| Delisle, MJ; Liehn, JC; Pérault, C; Schvartz, C; Wampach, H | 1 |
| Isobe, Y; Kihara, M; Kobayashi, S; Matsusaka, K; Miyauchi, A; Nishiyama, Y; Ohkawa, M; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
| Chisin, R; Glaser, B; Guttmann, H; Ish-Shalom, S; Krausz, Y; Rosler, A; Shibley, N | 1 |
| Hara, Y; Hayashi, A; Horiike, S; Ishii, K; Kubo, A; Kusakabe, K; Masaki, H; Murata, H | 1 |
| Besser, GM; Britton, KE; Chew, SL; Foley, R; Grossman, AB; Hikmat, J; Islam, N; Jenkins, PJ; Kaltsas, GA; Monson, JP; Mukherjee, JJ; Plowman, PN | 1 |
| Bais, E; Boot, H; de Kraker, J; Hoefnagel, CA; Taal, B; Valdés Olmos, RA; Vote, PA | 1 |
7 review(s) available for 3-iodobenzylguanidine and Carcinoma, Medullary
| Article | Year |
|---|---|
MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Humans; Neoplasm Metastasis; Neoplasm, Residual; Proto-Oncogene Mas; Recurrence; Thyroid Neoplasms | 2008 |
Radioiodinated metaiodobenzylguanidine treatment of neuroendocrine tumors in adults.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Carcinoid Tumor; Carcinoma, Medullary; Drug Interactions; Humans; Iodine Radioisotopes; Male; Medical Oncology; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Thyroid Neoplasms | 2009 |
Imaging of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; Catecholamines; Child; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Middle Aged; Neuroblastoma; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms | 2006 |
Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoembryonic Antigen; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2008 |
[Medullary carcinoma of the thyroid gland].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Child; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Iodine Radioisotopes; Iodobenzenes; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Parathyroid Hormone; Prognosis; Thyroid Neoplasms; Thyroidectomy | 1994 |
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Heart; Hormone Antagonists; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Sympathetic Nervous System; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
[Therapeutic advances of nuclear medicine in oncology].
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma; Carcinoma, Medullary; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Medical Oncology; Neoplasms; Neuroblastoma; Nuclear Medicine; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2001 |
4 trial(s) available for 3-iodobenzylguanidine and Carcinoma, Medullary
| Article | Year |
|---|---|
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Patient Selection; Pentetic Acid; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2004 |
[Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Positron-Emission Tomography; Remission Induction; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2006 |
[Detection of neural crest tumors by 123I-MIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Thyroid Neoplasms | 1994 |
[Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
14 other study(ies) available for 3-iodobenzylguanidine and Carcinoma, Medullary
| Article | Year |
|---|---|
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Pheochromocytoma: unusual presentation of a rare disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Medullary; Diagnosis, Differential; Disease-Free Survival; Follow-Up Studies; Humans; Low Back Pain; Lumbar Vertebrae; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Osteolysis; Pelvis; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed | 2002 |
Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Carcinoma, Medullary; Child; Female; Follow-Up Studies; Humans; Multiple Endocrine Neoplasia Type 2b; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
Detection of medullary carcinoma of the thyroid with I-131 MIBG.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Antineoplastic Agents; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid; Thyroid Neoplasms | 1994 |
131I-MIBG scintigraphy in neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma, Medullary; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neural Crest; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Neoplasms | 1994 |
Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Carcinoma, Medullary; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Organotechnetium Compounds; Radionuclide Imaging; Reagent Kits, Diagnostic; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thallium; Thallium Radioisotopes; Thyroid Neoplasms | 1994 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Carcinoma, Medullary; Child; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Heart; Humans; Hyperaldosteronism; Injections, Intravenous; Insulinoma; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Thyroid Neoplasms | 1995 |
Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents, Hormonal; Calcitonin; Carcinoid Tumor; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 1995 |
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Merkel Cell; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organotechnetium Compounds; Pheochromocytoma; Pituitary Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Sugar Acids; Technetium Compounds; Thyroid Neoplasms | 1995 |
Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Feasibility Studies; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Octreotide; Pentetic Acid; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Thoracic Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Carcinoma, Medullary; Humans; Hyperplasia; Iodine Radioisotopes; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 2b; Neoplasm Staging; Pheochromocytoma; Precancerous Conditions; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1998 |
Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multiple Endocrine Neoplasia Type 2b; Octreotide; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed; Trachea | 1999 |
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Medullary; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Thyroid Neoplasms; Treatment Outcome | 2001 |